Dalibor Sames

Company: Columbia University

Job title: Co-Founder, Gilgamesh Pharmaceuticals & Faculty

Seminars:

Workshop A: From Underlying Mechanisms to Clinical Efficacy: Deepening Understanding of the Psychedelic Mode of Action & Hallucinogenic Effects 9:00 am

Investment in psychedelic R&D is growing, with notable approvals on the horizon, however, the underlying mechanisms and receptor interactions driving clinical efficacy remain poorly understood. Join this workshop to uncover new knowledge of underlying psychedelic mechanisms, decipher the role of 5HT2A, debate the necessity hallucinogenic effects, and examine recent clinical efficacy data. Address critical questions,…Read more

day: Pre Conf Day - A